Table 4.
Prevalence definitiona | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Disease | ≥ 6 months enrollment |
≥ 12 months enrollment |
≥ mean enrollment of source populationd |
≥ mean enrollment of casesd |
Percent change in estiamte |
||||||
Drug benefitb |
Users of benefitc |
Drug benefitb |
Users of benefitc |
Drug benefitb |
Users of benefitc |
Drug benefitb |
Users of benefitc |
Drug benefitb |
Users of benefitc |
||
Crohn’s disease | Cases/100,000 | 155.8 | 173.9 | 173.2 | 186.6 | 199.6 | 213.9 | 214.9 | 221.8 | ||
n | 85,454 | 111,511 | 76,660 | 100,080 | 58,241 | 64,016 | 41,730 | 52,237 | |||
Ulcerative colitis |
Cases/100,000 | 140.1 | 157.0 | 159.9 | 172.8 | 195.7 | 213.3 | 220.5 | 228.1 | ||
n | 76,877 | 100,660 | 70,762 | 92,717 | 57,106 | 63,833 | 40,863 | 51,335 | |||
EoE | Cases/100,000 | 61.8 | 67.6 | 69.9 | 73.9 | 87.0 | 92.3 | 99.1 | 101.4 | ||
n | 33,903 | 43,356 | 30,919 | 39,644 | 25,382 | 27,618 | 18,363 | 22,810 | |||
Barrett’s esophagus |
Cases/100,000 | 131.2 | 151.8 | 153.2 | 171.1 | 194.9 | 217.1 | 225.2 | 237.0 | ||
n | 71,966 | 97,353 | 67,794 | 91,777 | 56,880 | 64,960 | 39,893 | 52,322 | |||
Celiac disease | Cases/100,000 | 58.6 | 66.5 | 67.0 | 73.3 | 83.6 | 91.2 | 94.2 | 98.8 | ||
n | 32,172 | 42,622 | 29,648 | 39,342 | 24,395 | 27,306 | 17,139 | 22,239 | |||
Source population |
n | 54,858,366 | 64,132,756 | 44,264,058 | 53,643,840 | 29,182,094 | 29,924,646 | Variablee | Variablef |
Definitions based on continuous enrollment for period specified for any enrollee meeting the enrollment definition specified during 2009–2012
Documentation of the enrollee having a prescription drug benefit as part of their health insurance plan
Documentation of the enrollee having at least 1 CPT, NDC, IDC-9, HCPCS code during the enrollment period specified
Definition for inclusion in source population based on individual having ≥ mean enrollment period of source population (622 days for drug benefit and 660 days for users of benefit) or cases (varies by disease condition as described in Table 2) within 2009–2012
Crohn’s disease – n=19,418,589; ulcerative colitis – n=18,534,133; EoE – n=18,534,831; Barrett’s esophagus – n= 17,718,307; celiac disease – n=18,187,751
Crohn’s disease – n=23,549,560; ulcerative colitis – n=22,508,811; EoE – n=22,504,132; Barrett’s esophagus – n= 22,074,561; celiac disease – n=22,499,335